Skip to main content

Exome Asset Management LLC

13F filer · CIK 0002011932
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$162MU.S. long equity reported on 13F
Positions5215 new · 8 closed
Net flow last quarter-$35.6MBuys minus sells
Top 10 positions weight44.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202652 positions
GHGuardant Health, Inc.$10.1M6.25%0.05%-18.4%Q1 2024
PRAXPraxis Precision Medicines, Inc.$9.11M5.62%0.10%-40.2%Q2 2025
TGTXTG Therapeutics, Inc.$9.06M5.59%0.11%Not reportedQ4 2023
COGTCogent Biosciences, Inc.$8.15M5.03%0.12%-24.4%Q1 2025
IONSIonis Pharmaceuticals Inc$6.99M4.31%0.05%-19.9%Q4 2024
LLYELI LILLY & Co$6.59M4.06%0.00%-21.7%Q4 2023
ABVXAbivax S.A.$6.25M3.85%0.06%NewQ2 2026
ALMSAlumis Inc.$5.75M3.55%Not reported-26.8%Q3 2025
CYTKCytokinetics Inc$5.12M3.16%0.05%-42.1%Q4 2023
ELVNEnliven Therapeutics, Inc.$5.09M3.14%0.14%-54.5%Q1 2024
VERAVera Therapeutics, Inc.$4.17M2.57%0.14%-15.4%Q2 2025
UNHUnitedhealth Group Inc$4M2.46%0.00%-25.3%Q4 2025
TXG10x Genomics, Inc.$3.93M2.43%0.08%-33.4%Q2 2025
NTRANatera, Inc.$3.75M2.31%0.01%-26.0%Q4 2023
QUREuniQure N.V.$3.73M2.30%0.12%Not reportedQ3 2025
RYTMRhythm Pharmaceuticals, Inc.$3.58M2.21%0.05%-20.6%Q4 2023
MAZEMaze Therapeutics, Inc.$3.42M2.11%0.21%+29.6%Q1 2026
GLUEMonte Rosa Therapeutics, Inc.$3.32M2.05%0.16%-23.6%Q1 2026
MLTXMoonLake Immunotherapeutics$3.24M2.00%0.23%-22.7%Q4 2023
ALKSAlkermes plc.$3.21M1.98%0.04%-27.1%Q1 2026
LQDALiquidia Corp$3.13M1.93%0.04%-14.4%Q2 2025
UTHRUNITED THERAPEUTICS Corp$2.93M1.81%0.01%-23.3%Q3 2025
GKOSGLAUKOS Corp$2.78M1.71%0.03%-4.9%Q3 2024
ARWRArrowhead Pharmaceuticals, Inc.$2.63M1.62%0.02%-29.5%Q1 2024
AGIOAgios Pharmaceuticals, Inc.$2.62M1.61%0.12%-43.6%Q1 2024
CBIOCrescent Biopharma, Inc.$2.3M1.42%0.46%-16.6%Q1 2026
AZNAstrazeneca PLC$2.25M1.39%Not reportedNot reportedQ1 2025
BSXBoston Scientific Corp$2.06M1.27%0.00%Not reportedQ4 2024
ADAGAdagene Inc.$2.05M1.27%0.82%-33.7%Q1 2024
PENPenumbra Inc$1.99M1.23%0.02%Not reportedQ4 2023
ISRGIntuitive Surgical Inc$1.95M1.20%0.00%-22.8%Q4 2023
VKTXViking Therapeutics, Inc.$1.87M1.15%0.04%NewQ2 2026
OCULOcular Therapeutix, Inc$1.78M1.10%0.08%Not reportedQ1 2024
EQEquillium, Inc.$1.77M1.09%0.87%NewQ2 2026
ASNDAscendis Pharma A/S$1.75M1.08%0.01%Not reportedQ2 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$1.73M1.07%0.99%-21.0%Q1 2024
CTMXCytomX Therapeutics, Inc.$1.73M1.06%0.21%-11.8%Q3 2025
VSTMVerastem, Inc.$1.64M1.01%0.47%-32.6%Q2 2025
NKTRNektar Therapeutics$1.56M0.97%0.11%Not reportedQ4 2024
CLPTClearPoint Neuro, Inc.$1.49M0.92%0.27%NewQ2 2026
INSMINSMED Inc$1.48M0.91%0.01%-48.0%Q4 2023
CAICaris Life Sciences, Inc.$1.39M0.86%0.03%NewQ2 2026
BBIOBridgeBio Pharma, Inc.$1.37M0.84%0.01%-72.8%Q4 2023
ZBIOZenas BioPharma, Inc.$1.33M0.82%0.08%-35.0%Q1 2026
NBPNovaBridge Biosciences$1.13M0.69%0.22%Not reportedQ1 2024
ESTAEstablishment Labs Holdings Inc.$1.12M0.69%0.04%Not reportedQ4 2023
RLAYRelay Therapeutics, Inc.$889K0.55%0.02%-82.9%Q3 2024
GERNGeron Corp$799K0.49%0.10%Not reportedQ4 2023
DRUGBright Minds Biosciences Inc.$710K0.44%0.13%NewQ2 2026
CMPXCompass Therapeutics, Inc.$605K0.37%0.15%NewQ2 2026
Q1 2026Reported May 15, 202645 positions
PRAXPraxis Precision Medicines, Inc.$14.6M7.58%0.16%-21.8%Q2 2025
COGTCogent Biosciences, Inc.$10.7M5.54%0.16%-8.9%Q1 2025
ELVNEnliven Therapeutics, Inc.$8.63M4.46%0.36%-1.0%Q1 2024
IONSIonis Pharmaceuticals Inc$8.26M4.27%0.07%-5.5%Q4 2024
GHGuardant Health, Inc.$7.64M3.95%0.06%-15.7%Q1 2024
CYTKCytokinetics Inc$6.84M3.54%0.08%-16.9%Q4 2023
LLYELI LILLY & Co$6.45M3.34%0.00%-10.7%Q4 2023
ALMSAlumis Inc.$6.15M3.18%Not reported-4.5%Q3 2025
BBIOBridgeBio Pharma, Inc.$5.01M2.59%0.03%-16.4%Q4 2023
VERAVera Therapeutics, Inc.$4.63M2.39%0.18%-7.6%Q2 2025
INSMINSMED Inc$4.36M2.25%0.01%Not reportedQ4 2023
ELVElevance Health, Inc.$4.3M2.22%0.01%-14.6%Q4 2025
AGIOAgios Pharmaceuticals, Inc.$4.23M2.19%0.21%-8.7%Q1 2024
UTHRUNITED THERAPEUTICS Corp$4.18M2.16%0.02%-8.2%Q3 2025
MLTXMoonLake Immunotherapeutics$4.01M2.08%0.41%Not reportedQ4 2023
NTRANatera, Inc.$3.73M1.93%0.01%Not reportedQ4 2023
RYTMRhythm Pharmaceuticals, Inc.$3.53M1.83%0.06%Not reportedQ4 2023
UNHUnitedhealth Group Inc$3.48M1.80%0.00%+120.4%Q4 2025
APLSApellis Pharmaceuticals, Inc.$3.44M1.78%0.07%-37.1%Q4 2023
VSTMVerastem, Inc.$3.37M1.75%0.72%+58.5%Q2 2025
TXG10x Genomics, Inc.$3.27M1.69%0.12%-5.8%Q2 2025
BSXBoston Scientific Corp$3.03M1.57%0.00%Not reportedQ4 2024
ALKSAlkermes plc.$2.97M1.54%0.05%NewQ1 2026
GLUEMonte Rosa Therapeutics, Inc.$2.95M1.53%0.21%NewQ1 2026
ISRGIntuitive Surgical Inc$2.93M1.52%0.00%Not reportedQ4 2023
ADAGAdagene Inc.$2.89M1.49%1.24%-30.5%Q1 2024
ARWRArrowhead Pharmaceuticals, Inc.$2.87M1.48%0.03%-8.1%Q1 2024
CBIOCrescent Biopharma, Inc.$2.81M1.46%0.56%NewQ1 2026
RLAYRelay Therapeutics, Inc.$2.77M1.43%0.15%Not reportedQ3 2024
MAZEMaze Therapeutics, Inc.$2.64M1.37%0.18%NewQ1 2026
CTMXCytomX Therapeutics, Inc.$2.45M1.27%0.31%-30.0%Q3 2025
AVTXAvalo Therapeutics, Inc.$2.38M1.23%0.65%Not reportedQ3 2025
GKOSGLAUKOS Corp$2.25M1.16%0.04%-33.7%Q3 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$2.2M1.14%1.32%+67.8%Q1 2024
PENPenumbra Inc$2.07M1.07%0.02%-30.0%Q4 2023
SLNOSoleno Therapeutics Inc$2.06M1.07%0.12%Not reportedQ4 2024
LQDALiquidia Corp$1.73M0.89%0.05%-49.8%Q2 2025
ZBIOZenas BioPharma, Inc.$1.58M0.82%0.13%NewQ1 2026
NBPNovaBridge Biosciences$1.42M0.73%0.22%+15.5%Q1 2024
FDMT4D Molecular Therapeutics, Inc.$1.22M0.63%0.25%NewQ1 2026
NXTCNextCure, Inc.$1.22M0.63%3.20%-30.0%Q4 2025
PALIPalisade Bio, Inc.$1.05M0.54%0.36%-20.9%Q4 2025
ESTAEstablishment Labs Holdings Inc.$744K0.38%0.04%Not reportedQ4 2023
LPCNLipocine Inc.$486K0.25%0.81%NewQ1 2026
ABUSArbutus Biopharma Corp$340K0.18%0.04%Not reportedQ4 2024
Q4 2025Reported Feb 13, 202653 positions
PRAXPraxis Precision Medicines, Inc.$17.1M8.19%0.23%-43.0%Q2 2025
COGTCogent Biosciences, Inc.$10.9M5.19%0.19%-31.1%Q1 2025
GHGuardant Health, Inc.$10M4.79%0.08%Not reportedQ1 2024
IONSIonis Pharmaceuticals Inc$9.22M4.41%0.07%-11.1%Q4 2024
LLYELI LILLY & Co$8.44M4.03%0.00%Not reportedQ4 2023
CYTKCytokinetics Inc$7.93M3.79%0.10%-12.4%Q4 2023
WVEWave Life Sciences, Inc.$7.17M3.43%0.22%Not reportedQ2 2024
VERAVera Therapeutics, Inc.$6.3M3.01%0.19%-20.3%Q2 2025
BBIOBridgeBio Pharma, Inc.$6.17M2.95%0.04%-39.4%Q4 2023
ELVElevance Health, Inc.$6.03M2.88%0.01%NewQ4 2025
AZNAstrazeneca PLC$5.26M2.52%Not reportedNot reportedQ1 2025
JAZZJazz Pharmaceuticals plc$4.5M2.15%0.04%NewQ4 2025
NTRANatera, Inc.$4.27M2.04%0.01%Not reportedQ4 2023
IMVTImmunovant, Inc.$4.03M1.93%0.08%Not reportedQ3 2025
UHSUniversal Health Services Inc$3.84M1.84%Not reported+121.6%Q2 2025
UTHRUNITED THERAPEUTICS Corp$3.74M1.79%0.02%+15.7%Q3 2025
AGIOAgios Pharmaceuticals, Inc.$3.73M1.78%0.23%Not reportedQ1 2024
IRONDisc Medicine, Inc.$3.71M1.77%0.12%-23.8%Q2 2024
ISRGIntuitive Surgical Inc$3.6M1.72%0.00%Not reportedQ4 2023
GKOSGLAUKOS Corp$3.55M1.70%0.05%+16.0%Q3 2024
ELVNEnliven Therapeutics, Inc.$3.42M1.64%0.37%Not reportedQ1 2024
CELCCelcuity Inc.$3.42M1.64%0.07%NewQ4 2025
APLSApellis Pharmaceuticals, Inc.$3.41M1.63%0.11%Not reportedQ4 2023
TVTXTravere Therapeutics, Inc.$3.4M1.63%0.10%-43.3%Q4 2023
DXCMDexcom Inc$3.33M1.59%0.01%Not reportedQ4 2023
ARWRArrowhead Pharmaceuticals, Inc.$3.3M1.58%0.04%-52.4%Q1 2024
CTMXCytomX Therapeutics, Inc.$3.17M1.52%0.44%Not reportedQ3 2025
LQDALiquidia Corp$3.14M1.50%0.10%-3.3%Q2 2025
VSTMVerastem, Inc.$3.1M1.48%0.52%Not reportedQ2 2025
ALMSAlumis Inc.$2.85M1.36%Not reported-0.2%Q3 2025
PENPenumbra Inc$2.8M1.34%0.02%Not reportedQ4 2023
TXG10x Genomics, Inc.$2.67M1.28%0.13%Not reportedQ2 2025
IMCRImmunocore Holdings plc$2.66M1.27%0.15%NewQ4 2025
EWTXEdgewise Therapeutics, Inc.$2.48M1.19%0.09%-42.3%Q3 2024
NXTCNextCure, Inc.$2.34M1.12%4.71%NewQ4 2025
BLTEBelite Bio, Inc$2.29M1.10%0.04%NewQ4 2025
WAYWaystar Holding Corp.$2.26M1.08%0.04%+47.1%Q2 2025
IRWDIronwood Pharmaceuticals Inc$2.19M1.04%0.40%NewQ4 2025
KPTIKaryopharm Therapeutics Inc.$2.18M1.04%1.61%NewQ4 2025
ADAGAdagene Inc.$2M0.96%1.79%Not reportedQ1 2024
NBPNovaBridge Biosciences$1.99M0.95%0.19%-65.3%Q1 2024
UNHUnitedhealth Group Inc$1.93M0.92%0.00%NewQ4 2025
PALIPalisade Bio, Inc.$1.78M0.85%0.48%NewQ4 2025
UPBUpstream Bio, Inc.$1.76M0.84%0.12%+24.8%Q3 2025
GOSSGossamer Bio, Inc.$1.4M0.67%0.19%Not reportedQ2 2024
IKTInhibikase Therapeutics, Inc.$1.23M0.59%0.46%NewQ4 2025
IQVIqvia Holdings Inc.$1.21M0.58%0.00%NewQ4 2025
THCTenet Healthcare Corp$1.21M0.58%0.01%-66.4%Q2 2025
CRBPCorbus Pharmaceuticals Holdings, Inc.$1.14M0.54%0.79%-39.3%Q1 2024
FULCFulcrum Therapeutics, Inc.$1.04M0.50%0.14%-6.8%Q2 2024
Q3 2025Reported Nov 14, 202552 positions
IONSIonis Pharmaceuticals Inc$8.57M5.19%0.08%+8.2%Q4 2024
CYTKCytokinetics Inc$7.83M4.74%0.12%+23.0%Q4 2023
BBIOBridgeBio Pharma, Inc.$6.91M4.19%0.07%-14.4%Q4 2023
COGTCogent Biosciences, Inc.$6.37M3.86%0.32%-16.9%Q1 2025
GHGuardant Health, Inc.$6.13M3.71%0.08%Not reportedQ1 2024
LLYELI LILLY & Co$5.99M3.63%0.00%+68.0%Q4 2023
NBPNovaBridge Biosciences$5.44M3.30%0.54%Not reportedQ1 2024
PRAXPraxis Precision Medicines, Inc.$5.41M3.27%0.48%+72.9%Q2 2025
VERAVera Therapeutics, Inc.$4.54M2.75%0.24%+103.5%Q2 2025
AZNAstrazeneca PLC$4.27M2.59%Not reportedNot reportedQ1 2025
IRONDisc Medicine, Inc.$4.05M2.46%0.18%Not reportedQ2 2024
ETNB89bio, Inc.$4.02M2.44%0.18%+17.2%Q3 2024
APGEApogee Therapeutics, Inc.$3.75M2.27%0.16%NewQ3 2025
TVTXTravere Therapeutics, Inc.$3.75M2.27%0.18%+2.4%Q4 2023
THCTenet Healthcare Corp$3.68M2.23%0.02%-33.0%Q2 2025
ARWRArrowhead Pharmaceuticals, Inc.$3.6M2.18%0.08%Not reportedQ1 2024
CVSCVS HEALTH Corp$3.29M1.99%0.00%NewQ3 2025
SLNOSoleno Therapeutics Inc$3.27M1.98%0.09%+16.3%Q4 2024
NTRANatera, Inc.$3M1.82%0.01%Not reportedQ4 2023
CRBPCorbus Pharmaceuticals Holdings, Inc.$2.91M1.76%1.83%-17.1%Q1 2024
ISRGIntuitive Surgical Inc$2.84M1.72%0.00%Not reportedQ4 2023
EWTXEdgewise Therapeutics, Inc.$2.81M1.70%0.16%+39.3%Q3 2024
UTHRUNITED THERAPEUTICS Corp$2.79M1.69%0.02%NewQ3 2025
AKROAkero Therapeutics, Inc.$2.78M1.68%0.07%Not reportedQ3 2024
IMVTImmunovant, Inc.$2.56M1.55%0.09%NewQ3 2025
GERNGeron Corp$2.55M1.54%0.29%-45.6%Q4 2023
CTMXCytomX Therapeutics, Inc.$2.38M1.44%0.45%NewQ3 2025
PENPenumbra Inc$2.28M1.38%0.02%Not reportedQ4 2023
GKOSGLAUKOS Corp$2.21M1.34%0.05%Not reportedQ3 2024
LQDALiquidia Corp$2.14M1.30%0.11%+359.7%Q2 2025
CNTACentessa Pharmaceuticals PLC$2.13M1.29%0.07%-47.3%Q1 2024
TXG10x Genomics, Inc.$1.91M1.16%0.13%Not reportedQ2 2025
CORCencora, Inc.$1.88M1.14%0.00%NewQ3 2025
SNDXSyndax Pharmaceuticals Inc$1.81M1.10%0.14%-61.8%Q4 2024
WAYWaystar Holding Corp.$1.78M1.08%0.03%Not reportedQ2 2025
UHSUniversal Health Services Inc$1.63M0.98%Not reported-21.2%Q2 2025
ORICOric Pharmaceuticals, Inc.$1.45M0.88%0.12%NewQ3 2025
PRCTPROCEPT BioRobotics Corp$1.42M0.86%0.07%NewQ3 2025
INSPInspire Medical Systems, Inc.$1.38M0.84%0.06%NewQ3 2025
QUREuniQure N.V.$1.29M0.78%0.04%NewQ3 2025
MLTXMoonLake Immunotherapeutics$1.28M0.77%0.34%Not reportedQ4 2023
AVTXAvalo Therapeutics, Inc.$1.27M0.77%0.56%NewQ3 2025
GOSSGossamer Bio, Inc.$1.19M0.72%0.20%-58.9%Q2 2024
ALMSAlumis Inc.$1.17M0.71%Not reportedNewQ3 2025
UPBUpstream Bio, Inc.$977K0.59%0.10%NewQ3 2025
MBXMBX Biosciences, Inc.$917K0.56%0.12%-16.9%Q1 2025
FULCFulcrum Therapeutics, Inc.$909K0.55%0.18%-77.8%Q2 2024
ESTAEstablishment Labs Holdings Inc.$537K0.33%0.05%Not reportedQ4 2023
ABUSArbutus Biopharma Corp$343K0.21%0.04%Not reportedQ4 2024
REPLReplimune Group, Inc.$308K0.19%0.09%-81.5%Q4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.